Dr. Vignesh Rajah Appointed as SERB Pharmaceuticals’ Chief Medical Officer

Core Insights - SERB Pharmaceuticals has appointed Dr. Vignesh Rajah as Chief Medical Officer, bringing over 20 years of global experience in the pharmaceutical and biotech sectors [1][2][3] Company Overview - SERB is a global specialty pharmaceutical company focused on rare emergency medicine and rare diseases, with a portfolio that includes medical countermeasures and antidotes [4] - The company has been operational for over 30 years and distributes essential medicines in over 100 countries, emphasizing its ability to meet critical medical needs [4] Strategic Importance of Appointment - Dr. Rajah's role as CMO is seen as pivotal for advancing SERB's scientific and medical capabilities, supporting new product launches, and enhancing engagement with the medical community [2][3] - The appointment is expected to align with SERB's commitment to improving patient care and health outcomes, particularly in the areas of rare diseases and emergency medicines [3] Leadership and Experience - Dr. Rajah previously served as CMO at Y-mAbs Therapeutics Inc. and held senior medical roles at major pharmaceutical companies such as Sanofi, Wyeth, and GSK, with expertise in various therapy areas including oncology and immunology [3]